[LXRX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 1,082.21%
YoY- 921.77%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 9,163 7,999 8,727 294,448 9,682 9,216 17,071 -33.97%
PBT -69,071 -66,611 -51,138 220,072 -23,018 -21,797 -16,781 157.05%
Tax 5,125 958 335 -6,014 -219 789 -102 -
NP -69,071 -66,611 -51,138 226,086 -23,018 -21,797 -16,781 157.05%
Tax Rate - - - 2.73% - - - -
Total Cost 78,234 74,610 59,865 68,362 32,700 31,013 33,852 74.88%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -753.80 -832.74 -585.97 76.78 -237.74 -236.51 -98.30 289.35%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.65 -0.63 -0.48 2.13 -0.22 -0.21 -0.16 154.81%
EPS Diluted -0.65 -0.63 -0.48 1.95 -0.22 -0.21 -0.16 154.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.